Next Article in Journal
Enhancing the Wound Healing Effect of Conditioned Medium Collected from Mesenchymal Stem Cells with High Passage Number Using Bioreducible Nanoparticles
Previous Article in Journal
Skin Doctor: Machine Learning Models for Skin Sensitization Prediction that Provide Estimates and Indicators of Prediction Reliability
Previous Article in Special Issue
Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 20
Issue 19
10.3390/ijms20194834
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells

by
Yan Xu
1,2,
Jing-Jing An
1,2,
Dina Tabys
1,2,
Yin-Dan Xie
1,2,
Tian-Yu Zhao
1,2,
Hao-Wei Ren
1,2,* and
Ning Liu
1,2,*
1
Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin 150030, China
2
College of Food Science, Northeast Agricultural University, Harbin 150030, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(19), 4834; https://doi.org/10.3390/ijms20194834
Submission received: 21 August 2019 / Revised: 21 September 2019 / Accepted: 25 September 2019 / Published: 28 September 2019
(This article belongs to the Special Issue Osteoblasts and Osteocytes)
Browse Figures
Versions Notes

Abstract

:
Lactoferrin (LF) has demonstrated stimulation of osteogenic differentiation of mesenchymal stem cells (MSCs). Long non-coding RNAs (lncRNAs) participate in regulating the osteogenic differentiation processes. However, the impact of LF on lncRNA expression in MSC osteogenic differentiation is poorly understood. Our aim was to investigate the effects of LF on lncRNAs expression profiles, during osteogenic differentiation of rat bone marrow mesenchymal stem cells (rBMSCs), by RNA sequencing. A total number of 1331 putative lncRNAs were identified in rBMSCs during osteogenic differentiation in the study. LF influenced the expression of 120 lncRNAs (differentially expressed lncRNAs [DELs], Fold change > 1.5 or < −1.5; p < 0.05) in rBMSCs on day 14 of osteogenic differentiation, consisted of 60 upregulated and 60 down-regulated. Furthermore, the potential functions of DELs were of prediction by searching their target cis- and trans-regulated protein-coding genes. The bioinformatic analysis of DELs target gene revealed that LF led to the disfunction of transforming growth factor beta stimulus (TGF-β) and positive regulation of I-κappa B kinase/NF-κappa B signaling pathway, which may relate to osteogenic differentiation of rBMSCs. Our work is the first profiling of lncRNA in osteogenic differentiation of rBMSCs induced by LF, and provides valuable insights into the potential mechanisms for LF promoting osteogenic activity.

Graphical Abstract

1. Introduction

Bone marrow mesenchymal stem cells (BMSCs) are known to be an essential sources of progenitor cells, with multipotent and self-renewal capacity to differentiate into various cell types, including chondrocytes, osteoblasts, and adipocytes [1,2]. The osteogenic differentiation of BMSCs is responsible for bone formation, regeneration, and repair [3]. In recent times, some naturally existing nutrients and bioactive compounds, including fatty acid [4], carotenoids [5,6], flavonoids [7,8] phenolic acids [9], and peptides [10,11] have shown that enhanced osteogenic differentiation of osteoblasts and mesenchymal stem cells (MSCs) have attracted more attention as a source of clinical and functional food applications for improving bone health. Lactoferrin (LF), an iron-binding glycoprotein in the transferrin family, existed in mammalian biological secretory fluids (such as milk, saliva, and other exocrine secretion) [12]. It is reported that LF significantly enhances bone regeneration capacity in a calvarial defect rat model [13] and distraction osteogenesis in rabbit model [14]. LF also conserves bone homeostasis in ovariectomized BALB/c mice [15]. In addition, LF exhibits a promising role in the stimulation of osteogenic differentiation of osteoblasts [16], adipose stem cells [17], and MSCs [18]. Thus LF is a potent anabolic bone formation and growth factor, and has developed as an effector molecule on bone remodeling. However, the mechanisms of LF-promoting osteogenic activity were unclear.
Several studies attempted to investigate mechanisms underlying the osteotropic activity of LF. For example, it was suggested that LF stimulates osteoblast proliferation through binding to low-density lipoprotein receptor-related protein 1 (LRP1) and as a result activates the MAPK-extracellular signal regulated kinase (ERK) 1/2 [19]. The MAPK signaling pathway participates in the promotion of osteoblasts proliferation and osteoblast differentiation by LF [16,20]. Moreover, LF induces osteoblast osteogenic differentiation by binding to TGF-β receptor II followed activation of TGF-β signaling pathway [18,21]. Collectively, these studies indicate that LF promoting osteoblast osteogenic activity is involved in various signaling pathways, but the mechanism of LF in osteogenic differentiation of BMSCs is not fully understood. The long non-coding RNAs (lncRNAs) have been shown to regulate osteogenic differentiation of MSCs [22,23,24]. However, it has not been reported whether LF has had an effect on lncRNA expression during osteogenic of BMSCs, which is important for LF applied in functional food and therapeutic effects in promoting bone remodeling and bone health.
The lncRNAs are a heterogeneous class of long transcripts [>200 nucleotides (nt)] without protein-coding potential [25]. They modulate various biological processes, including cell growth, differentiation, and transcriptional regulation [26,27,28]. The lncRNAs have a special role in the osteogenic differentiation of MSCs at transcriptional, post-transcriptional, and post-translational levels [29,30], such as regulated osteogenic lineage-associated gene transcription via relation to adjacent mRNA, regulation of transcription factors by modulation of histone acetylation status, modulated osteogenic differentiation by playing a role of transcription factors decoys, and modulated osteogenesis by targeting microRNAs. Upregulation of lncRNA MEG3 partly promotes osteogenic differentiation of MSCs by activating bone morphogenetic protein 4 (BMP4) transcription, which is identified as a regulator of cartilage and bone formation [31]. Also, lncRNA KCNQ1OT1 promotes bone morphogenetic protein 2 (BMP2) expression and regulates osteogenic differentiation by sponging miRNA-214 [32]. In another study, the differentiation antagonizing non-protein coding RNA (DANCR) participates and regulates the proliferation and osteogenic differentiation of mesenchymal stem cells, derived from human bone marrow, through the p38 MAPK pathway [33]. Furthermore, lncRNA HOXA-AS2 was observed to enhance the osteogenesis positive regulation in mesenchymal stem cells by inactivating the NF-κappa B signaling [34]. The above research show the lncRNA participates in the regulation of osteogenic differentiation of MSCs via various pathways, the mechanism of LF-promoting MSCs osteogenic activity has yet to be elucidated. We assume that the contribution of LF in promoting osteogenic differentiation of MSCs may be through affecting the lncRNA expression which may regulate osteogenic differentiation.
Here, we employed a high-throughput RNA sequencing (RNA-seq) approach to explore the expression profiles of lncRNAs in control rBMSCs (CON group) and LF-treated rBMSCs (LF group), with the goal of better understanding the potential role of differential expression of lncRNAs in rBMSCs during osteogenic differentiation by lactoferrin. Herein, our work expands the lncRNAs roles in rBMSCs osteogenic differentiation treated by LF, and to provide new insights into LF development for promoting bone health.

2. Results

2.1. The Effect of LF on Osteogenic Differentiation Capacity of rBMSCs

Osteogenic differentiation of untreated control rBMSCs (CON group) and LF-treated rBMSCs (LF group), were evaluated by examining the early markers of osteogenic differentiation alkaline phosphatase (ALP) level, the later stage marker, osteocalcin (OCN) level, and most abundant protein in bone matrix collagen I (COL I) level on day 7, 14, and 21. The results are presented in Figure 1. The ALP activity of LF group increased significantly (p < 0.05) compared with the CON group (Figure 1A). Also, a higher expression level (p < 0.05) of COL I in the LF group was shown compared with the CON group (Figure 1B). According to OCN results (Figure 1C), the LF group significantly increased (p < 0.05) OCN level compared with the CON group. The calcium deposition, which is a late differentiated marker of osteogenic differentiation, was measured through Alizarin Red S staining. Compared with the CON group, the mineralization increased in the LF group on day 21 (Figure 1D). These results suggest that LF enhanced osteogenic differentiation of rBMSCs, especially on day 14. Therefore, we selected the rBMSCs on day 14 after treatment by LF to analyze the lncRNA profiles by RNA sequencing.

2.2. The Effect of LF on lncRNAs Profiles During Osteogenic Differentiation of rBMSCs

We performed identification and profiling of lncRNAs during osteogenic differentiation of CON group and LF groups on day 14 using RNA-seq methodology (Figure 2A). Total RNA was extracted from rBMSCs, and purified from ribosomal RNA, and the fragments were then converted into libraries for high throughput RNA sequencing. After discarding the adaptor and low-quality sequences, raw data consisting of > 152,017,088 clean reads from the Illumina HiSeq 2000 platform were obtained (Table 1). After stringent filtering, clean reads were aligned to the rat reference genome (Available online: ncbi.nlm.nih.gov/genomes: GCF_000001895.5_Rnor_6.0). A highest mapping rate of > 91.17% was in both CON group and LF group (Table 1).
Based on the specific structure and non-coding characteristics of lncRNAs, the transcripts were obtained through 4 steps to identify the annotated and novel lncRNAs (Figure 2B). For identification of lncRNAs, CNCI, CPC, and Pfam software were used and 1331 novel lncRNAs were identified (Figure 2C). According to the relative genomic locations with the coding genes, the identified novel lncRNAs were divided into five classifications (Figure 2D), including 121 of long intergenic lncRNAs or lincRNAs, 325 of intronic lncRNAs, 548 of anti-sense lncRNAs.

2.3. Characteristics of lncRNAs and mRNAs

In our work, in general, we identified a total of 2843 lncRNA (2309 known lncRNAs and 534 novel lncRNAs) and 11,961 mRNA (11,633 known mRNAs and 328 novel mRNAs) in rBMSCs. To characterize the identified lncRNAs, exon number, open reading frame (ORF) length, transcript count, transcript length, and expression density distribution were compared between lncRNAs and mRNAs of rBMSCs (Figure 3). The results revealed a significant differences in the number of exons between lncRNAs and mRNAs; approximately 81.14% of lncRNA transcripts contained 2–4 exons, while only 18.40% of mRNAs transcripts contained 2–4 exons (Figure 3A). Most of mRNAs show longer ORFs length than that of lncRNAs, most lncRNAs (68.31%) consisted of 100 to 300 nt; while about 67.74% of mRNAs consisted ≥ 800 nt (Figure 3B). Furthermore, the distribution of transcripts count showed that most of both lncRNAs (90.74%) and mRNAs (70.14 %) have one or two genes transcripts (Figure 3C). The length of lncRNAs transcripts (55.81%) ranged from 200 to 1600 and most of mRNAs transcripts (44.04%) showed length of ≥ 3000 nt (Figure 3D). These results are in accordance with the findings of previous studies, which concluded that lncRNAs have shorter transcripts and fewer exons than protein-coding genes [35,36,37]. However, lncRNA showed higher expression levels than transcripts of protein coding genes (Figure 3E), which was not consistent with the results of the literature [38].

2.4. The Effect of LF on Profiles of Differentially Expressed mRNAs and lncRNAs During Osteogenic Differentiation in rBMSCs

To explore the profiles of differentially expressed mRNAs and lncRNAs during osteogenic differentiation of CON group and LF group, gene expression levels, in terms of transcripts, were quantified by reads per kilo bases per million reads (RPKM) method using HTSeq in Python. Gene expression density distribution (Figure S1A,B) shows that the LF group and CON group were significantly different in genes expression. For principal component analysis (PCA), the loadings for PC1 and PC2 of CON and LF groups (Figure S1C) show that the two groups had a cluster of genes and the gene expression patterns in different samples of each group were highly correlated.
In total, the treatment with LF influenced the expression of 427 genes [Fold change > 1.5 or < −1.5; p < 0.05] in rBMSCs on day 14 of osteogenic differentiation (Table S2). Four hundred twenty-seven differentially expressed genes (DEGs), including 120 lncRNAs, 296 mRNA, 8 misc_RNA (Ptger2, LOC108350053, Cyp27a1, LOC102555503, Tmem131, LOC102551633, Dhodh, LOC100362344), and 3 precusor_RNA (Mir3574, Mir3588, Mir29b2), and 3 precusor_RNA (Mir3574, Mir3588, Mir29b2).
The differentially expressed LncRNAs (DELs) between CON and LF groups were used to generate a heatmap (Fold change > 1.5 or < −1.5; p < 0.05) in unsupervised hierarchical clustering analysis (Figure 4A), the cluster analyses of DELs show two groups could be separate. The heatmap of the differentially expressed mRNAs (DEMs) between CON and LF groups was shown in Figure 4B, which show DEMs in two groups were separated. These selected lncRNA and mRNA expression of rBMSCs during osteogenic differentiation were significantly affected by lactoferrin.
The statistical significance of these differentially expressed lncRNAs, as well as mRNAs in comparison of CON group with LF group (Fold change > 1.5 or < −1.5; p < 0.05) were depicted through volcano plots (Figure 4C,D). Additionally, we identified a total of 120 differentially expressed lncRNAs in LF group, compared with CON group (Fold change > 1.5 or < −1.5; p < 0.05); sixty of them were upregulated and other 60 were downregulated in rBMSCs, on day 14 of osteogenic differentiation in LF group, compared with CON group (Figure 4C). On the other hand, we identified a total of 296 differentially expressed mRNAs in LF group, compared with CON group (Fold change > 1.5 or < −1.5); one hundred forty-four of them were upregulated and 152 were downregulated in LF group compared with CON group (Figure 4D).
To validate the reliability of the RNA-seq data, we measured expression of the selected five differentially expressed mRNAs and lncRNAs through quantitative real-time PCR (qRT-PCR) validation. In accordance with the RNA-seq data, the two down-regulated lncRNAs were LOC102547244 and LOC108353231, and the three up-regulated lncRNAs were LOC102552879, LOC108348506, and Pvt1 (Figure 4E). However, the three down-regulated mRNAs were Kcnt1, Pllp, and Map3k8; and the two down-regulated mRNAs were Bmper and Smarcad1 (Figure 4F). The results of qRT-PCR are highly consistent with the RNA-seq results.

2.5. GO and KEGG Pathway Analysis of DEGs

To enrich the significant functions of the differentially expressed genes (DEGs), obtained during osteogenic differentiation of CON and LF groups, GO and KEGG pathway analyses were performed. A total number of 427 DEGs were mainly enriched in categories related to 325 GO functions under biological processes, cellular components, and molecular functions (Table S3), where the most enriched 30 GO terms (Figure 5A) were related to cell morphogenesis, release of cytochrome c from mitochondria, mRNA splicing, via spliceosome and so on.
The KEGG database was used to verify the pathways associated with the possible functions of the DEGs, obtained during osteogenic differentiation of CON and LF groups. Enrich 212 pathways (Table S4), top 30 enriched pathways (Figure 5B), including purine metabolism (nucleotide), pyruvate metabolism (carbohydrate metabolism), phosphatidylinositol signaling system (signal transduction), homologous recombination (replication and repair), carbon metabolism, MAPK signaling pathway (signal transduction), p53 signaling pathway (Cell growth and death), Calcium signaling pathway, and Ras signaling pathway and so on.

2.6. Target-gene Prediction of cis- and trans- lncRNA and lncRNA-mRNA Co-expression Networks

To understand how LF contributes to the expression of lncRNAs of rBMSCs during osteogenic differentiation, the potential targets of differentially expressed lncRNAs were predicted via cis- or trans-regulatory manner. For cis action, the genes within the range of 100 kb range of differentially expressed lncRNAs were selected to be the target coding genes, a total of 28 of differentially expressed lncRNAs’ transcripts related to 32 mRNA transcripts within the given range (100 kb) were predicated (Table S5). For trans action, we selected the correlation between lncRNAs and mRNAs with Pearson correlation coefficients not less than 0.8, and over 13 differentially expressed lncRNAs, corresponding to 136 genes for trans regulation, were predicted (Table S6).
To examine whether these highly conserved lncRNAs and their adjacent protein-coding genes mediate the regulation of osteogenic differentiation of rBMSCs, thirty-six lncRNAs corresponding to 146 mRNAs networks defining the co-expression of genes and lncRNAs and protein coding genes were constructed (Figure 6). The results show that LOC 102550676, XLOC_067508, XLOC_069296, XLOC_044922, LOC 102547955, LOC 102547955, LOC 102547955, LOC 102552031, LOC 108348833, and XLOC_002551 were the key genes regulators, and were correlated with their adjacent genes, specifying an essential important role in the regulation of osteogenic differentiation of LF-treated rBMSCs.
Generally, 146 target genes were predicted as targets of 36 differentially expressed lncRNAs, which were annotated by KEGG database and GO enrich analysis. In addition, 146 genes were classified as known genes, according to the KEGG database, which target genes related to KEGG pathway including: rno05416:Viral myocarditis, rno04210:Apoptosis, rno05152:Tuberculosis, rno05010:Alzheimer’s disease, rno05134:Legionellosis, rno04115:p53 signaling pathway, rno04514:Cell adhesion molecules (CAMs), these pathways may be related to regulation of osteogenic differentiation of rBMSCs (Table S7). The data of GO analysis, related to the osteogenic differentiation of a cellular response to transforming growth factor beta stimulus (TGF-β), positive regulation of glomerular mesangial cell proliferation, regulation of ventricular cardiac muscle cell action potential, SMAD binding, and positive regulation of I-κappa B kinase/NF-κappa B signaling, are shown in Table S8. The results show that the mechanism for enhancement of the osteogenic differentiation of rBMSCs by LF-treatment might be attributed to regulation of lncRNAs expression.

3. Discussion

LF is one of the most promising functional food ingredients present in milk, with many biological functions [39], especially for LF-promoting stem cell proliferation and osteogenic differentiation, and in protecting against apoptosis [17,40,41,42], attracting interest from bone health scientists and researchers. Therefore, understanding the underlying mechanism for the enhancement of osteogenic differentiation of BMSCs, induced by LF, will contribute to its application in food and therapeutic industries. In our present study, we investigated whether LF has a potential effect on lncRNAs expression profiles during the osteogenic differentiation of rBMSCs. To clarify the effect of LF on lncRNA expression profiles, we performed lncRNA expression profiles by RNA-seq through Illumina HiseqTM 2000 high throughput sequencer platform. The results show that lactoferrin affected the lncRNAs expression during osteogenic differentiation in rBMSCs, thus the mechanism of osteotropic activity of LF referred to the lncRNA regulation. To the best of our knowledge, this is the first study that has investigated the changes in profile expression of lncRNAs, during osteogenic differentiation of LF-treated rBMSCs culture, and explored the underlying mechanism of rBMSCs for promoting osteogenic activity induced by LF via RNA-seq.
In our study, LF at concentrations of 100 µg/mL was used for treatment of rBMSCs because this concentration was found to significantly promote proliferation in our previous study [43]. In some studies, 100 μg/mL LF has the best effect on promoting osteoblast proliferation and osteogenic differentiation [16,20]. In addition, 100 μg/mL LF also significantly stimulates proliferation and osteogenic differentiation of human adipose stem cells [17] and C3H10T1/2 Mesenchymal Stem Cells [18]. The alkaline phosphatase (ALP) is the early marker of osteogenic differentiation [44]. LF significantly enhances ALP expression of C3H10T1/2 mesenchymal stem cells on day 7 of osteogenic differentiation [18], and significantly promotes the ALP expression of MEG63 human osteoblast-like cells on day 14 of osteogenic differentiation [45]. The results of these studies were consistent with our results (Figure 1A). However, in Montesi et al. studies, 10 μg/mL LF decreases ALP level of MSCs on day 14 of osteogenic differentiation, compared with the control group [40], which is inconsistent with our research. This inconsistency may be attributed to the different cell origins, LF concentrations, and ALP assay methods used in our study. COLI and OCN are maturation state marker or transcription factors of osteogenic differentiation. OCN is involved in controlling the mineralisation process, which appeared at a late stage of osteogenic differentiation. Zou et al. found that OCN expression has the highest expression level on day 21 during osteogenic differentiation [44], which is similar with our results (Figure 1C). Takayama et al. showed that LF has a promoting effect on calcium deposition of MEG63 cells on day 21 of osteogenic differentiation [45], which is consistent with our results (Figure 1D). The promoting of osteogenic differentiation of rBMSCs by LF treatment was verified via analysis of ALP, COLI, OCN expression, and the calcium deposition during osteogenic differentiation of rBMSCs on day 7, 14, and 21. The obtained results reveal that lactoferrin enhanced the osteogenic differentiation of rBMSCs apparently. In our study, LF significantly increased the related osteogenic differentiation marker expression on day 14 of osteogenic differentiation of rBMSCs, which coincided with the report of Jiang et al. [46], thus, differential expression profiles of lncRNAs and mRNAs in rBMSCs, and the effect of LF on day 14, were studied by RNA-seq.
Our study is the first lncRNA profiling analysis of rBMSCs induced by untreated and treated-LF during osteogenic differentiation on day 14 by high throughput sequencing. In general, a total of 2843 lncRNA (2309 known lncRNAs and 534 novel lncRNAs) and 11,961 mRNA (11,633 known mRNAs and 328 novel mRNAs) were identified, in comparison with mRNAs, the lncRNA transcripts contained fewer exons, show shorter overall transcripts length and ORF length, which was in agreement with previous reports from others studies [35,36,37]. Moreover, compared with mRNAs, the lncRNAs have a higher expression level. This is inconsistent with other studies, which may be due to the reads per kilo bases per million reads (RPKM), used to evaluate the expression of transcripts in our study, not fragments per kilo-base of exon per million fragments mapped (FPKM). In short, our study firstly exhibits the feature of mRNA and lncRNA during osteogenic differentiation of rBMSCs, treated by LF, and shows that the LF-inducing osteogenic activity not only existed through the regulation of transcriptional level, but might also be related to the participation in of lncRNA in post-transcriptional and post-translational levels.
Mechanism of MSCs osteogenic differentiation is regulated by complex pathways at transcriptional, post-transcriptional and post-translational levels [42,47,48,49,50], and the related osteogenesis signaling pathways, including TGF-β signaling [21], Wnt signaling [51], Hedgehog [52], Notch [53], NF-κappa B signaling [5], Ras [54], and Calcium Signaling [55]. In our study, a total number of 427 differential genes were identified and found to be related to osteogenic development pathways, such as MAPK signaling pathway, p53 signaling pathway (Cell growth and death), calcium signaling pathway and so on. Evidences have shown that LF have a capacity of modulating bone formation and bone resorption, LF can regulate osteoblast differentiation through PKA and p38 MAPK pathways by lactoferrin’s Receptor LRP1 [16,56], and promote cell proliferation via MAPK signaling pathways [20]. Also, the MAPK signaling pathway have been demonstrated be associated with osteogenic differentiation of human bone marrow mesenchymal stem cells [57]. In this study, the JNK/p38 MAPK pathway (downregulated gene, including IL1R, Cdc42, Map3k8, upregulated gene, including Dusp7, Cacna1c) is suggested to be involved in the effect of LF on rBMSCs osteogenic differentiation. In particular, p53 was found to suppress the expression of Runx2 [58] and Osx [59], and in modulating osteoblast differentiation [60]. In our results, p53 (downregulated gene, including cd82, Pmaip1, Shisa8, Zfp385c) is shown to be involved in osteogenic differentiation of LF-treated rBMSCs. In addition, the mRNA expression of calcium channels (cacana1c, cacana1e, cana1g and cacna1i) were activated during osteogenic differentiation [61]. Meanwhile, the calcium signaling pathway was affected in the osteogenic differentiation of mesenchymal stem cells [62]. In our work, calcium signaling pathway regulation genes, including Bdkrb1, Cacna1c, Rcn1, Cabp4, and Itpkc were upregulated, and genes, including Tmem45b, Cxcl17, were downregulated. Collectively, these results show that enhancement of osteogenic differentiation of rBMSCs by LF may be associated to the MAPK signaling pathway, p53 signaling pathway, and calcium signaling pathway, which pathways may be regulated by the different expression mRNA and lncRNAs. However, the effect of LF on lncRNA expression profiling of rBMSCs, during osteogenic differentiation, is not reported. Our results show that LF contributed to altering the lncRNA and mRNA expression, which participated in the osteogenic differentiation of rBMSCs.
The lncRNAs are long noncoding RNA that regulate the functions of genes and proteins through various mechanisms, including the modulation of in epigenetic, transcriptional, and post-transcriptional gene and other specific regulation modes [22,23,28]. Previous studies have demonstrated that lncRNA regulates osteogenic differentiation of osteoblast and MSCs [63,64,65,66,67]. In this study, LF affected lncRNA profiles of rBMSCs during osteogenic differentiation through 60 upregulated and downregulated lncRNAs (p < 0.05, Fold change > 1.5 or < 1.5). Since lncRNAs are able to modulate the expression of protein coding genes in cis or trans [68], among the dysregulated lncRNA transcripts, we predicted the target gene according to the position of the differentially expressed lncRNAs, and their relationship with mRNAs via a cis- or trans-regulatory manner. In total, 36 lncRNAs corresponding to 146 mRNAs networks describing the co-expression of genes and lncRNAs were identified, indicating a potentially important role in regulating the changes in genes expression in LF-treated rBMSCs. The GO and pathway results of DELs target genes suggested a possible involvement of DELs in a variety of biologicals processed, such as a cellular response to transforming growth factor beta stimulus (TGF-beta signaling pathway), co-SMAD binding, and I-κappa B kinase/NF-κappa B signaling, which are likely to be related to osteogenic differentiation or bone formation. Zhang et al. [69] reported that, during osteogenic differentiation of human bone marrow mesenchymal stem cells, the lncRNA may participate in the regulation of MAPK signaling pathway and TGF-beta signaling pathway, which are associated with osteogenic differentiation. Moreover, TGF-beta signaling pathway was related to adipose-derived mesenchymal stem cells osteogenesis and bone formation of miR-10b via target gene Smad2 [70]. In our results, lncRNA target gene related to cellular response to transforming growth factor beta stimulus (TGF-β) (target gene Cav1, Id1, Usp9x, Apaf1) and co-SMAD binding (target gene, Usp9x, Tgif1). Usp9x is an important osteogenic regulating protein, which plays a major role in activating BMP signaling [71]. Therefore, the lncRNA LOC102552031 may participate in regulation of the osteogenic differentiation of LF-treated rBMSCs via target Usp9x in trans. In positive regulation of I-κappaB kinase/NF-κappaB signaling pathway (target gene Cflar, Casp8, Ticam2, Tmem101), Cflar and Casp8 play a critical role in autophagy, necroptosis, and apoptosis [72]. Therefore, LOC102552031 and XLOC_067508 lncRNAs may regulate the apoptosis process of rBMSCs via target gene Cflar and Casp8 in trans. The obtained results indicate that lncRNAs have a potentially important role in the regulation of LF-treated rBMSCs differentiation. However, the precisely regulated function of lncRNA in osteogenic induced by LF will be further verified by other manners. Herein, we concluded that LF, affected lncRNAs and mRNAs expression, which contributed to the osteogenic differentiation of rBMSCs via complex signaling pathway. Generally, the function of lncRNAs is reflected by their effects on adjacent gene protein-coding genes via cis and trans manner.
These results may help understand the role of lncRNAs in the enhancement of the osteogenic differentiation of MSCs by LF. However, the mechanism of regulation during osteogenic differentiation of rBMSCs, by differentially expressed lncRNAs function, is still unclear and warrants further investigation.

4. Materials and Methods

4.1. Cell Culture

Primary Sprague Dawley (SD) rat bone mesenchymal stem cells (rBMSCs) were purchased from the Cell Bank of Typical Culture Preservation Committee of Chinese Academy of Science (Shanghai, China). The cells were cultivated in Dulbecco’s Modified Eagle Medium (DMEM; Gibco life technologies Co. Ltd. Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS, Gemini Bio-Products, West Sacramento, CA, USA), 100 U/mL penicillin and 100 mg/mL streptomycin, at 37 °C in 5% CO2. After reaching 80% confluency, rBMSCs were passaged using 0.25% trypsin-EDTA (Gibco life technologies Co. Ltd. Carlsbad, CA, USA). Cells at passage 3 and 4 were used in the experiments.

4.2. Osteogenic Differentiation of rBMSCs

For the osteogenic differentiation assays, rBMSCs were seeded into a 6-well tissue plate, at a cell density of 1 × 106 cells/well, and cultured in osteogenic differentiation medium (Cyagen Biosciences Inc. Guangzhou, China) with (100 μg/mL) or without bovine lactoferrrin (LF, 96.3% of purity, Westland Co-operative Dairy Co. Ltd., Hokitika, New Zealand, and the iron saturation of bovine lactoferrin was 15%) for 7, 14, and 21 days and the medium renewed every 3 days of the culture. The cells were then rinsed twice with phosphate buffered saline (PBS) (Solarbio Science and Technology Co. Ltd. Beijing, China). Markers of osteogenic differentiation-alkaline phosphatase (ALP), collagen I (COL I), osteocalcin (OCN) secretion were detected in cell culture supernatants with an enzyme-linked immune-sorbent assay (ELISA) kit (Jianglai Bio, Shanghai, China) following the product manufacturer’s instructions and measured at a wavelength of 450 nm by multifunctional microplate reader scanning (Infinite M200PRO, TECAN, Männedorf, Switzerland).

4.3. Alizarin Red Staining of rBMSCs

Alizarin red staining performed in the extracellular matrix mineralization of osteogenic differentiation of rBMSCs in cultured with, or without, 100 μg/mL LF for a period of 7, 14, and 21 days. Briefly, rBMSCs were rinsed twice with PBS, followed by fixed for 30 min in 4% paraformaldehyde. After rinsing the cells twice using PBS, rBMSCs were stained using 1% alizarin red S for 15 min at room temperature and observed under the microscope (JEM-1200EX, Hitachi, Tokyo, Japan).

4.4. RNA Extraction, Library Construction, and High-throughput RNA Sequencing (RNA-Seq)

The total RNA was extracted through TRIzol reagent (Invitrogen Corp., Carlsbad, CA, USA) according to the manufacturer’s instructions and their integrity was examined. Quantitative analysis of total RNA, using an RNA 6000 Nano Kit (Agilent Technologies, Palo Alto, CA, USA), by an Agilent 2100 Bio analyzer (Bioanalyzer 2100 system) was conducted.
To ensure accurate lncRNA analysis, ribosomal RNA was removed from the RNA through Ribominus kit (Life Technologies, Foster City, CA, USA). RNA samples from three rBMSCs groups with RNA Integrity Number (RNI) ≥ 8 were subjected to library construction and high-throughput RNA sequencing (RNA-seq) at Beijing Genome Institute (BGI, Beijing, China), using an Illumina HiSeq™ 2000 high throughput sequencer platform with 100 paired end sequencing, according to the manufacturer’ specifications.
Low-quality reads were removed, and the raw reads trimmed and mapped against the rat reference genome in NCBI (Available online: ncbi.nlm.nih.gov/genomes: GCF_000001895.5_Rnor_6.0) with HISAT (hierarchical indexing for spliced alignment of transcripts) version 0.1.6 [73]. The mapped reads were assembled into contigs using StringTie version 1.0.4.4.1 [74] and Cufflinks version 2.2.1 [75].

4.5. LncRNAs Identification and Classification

To identify the putative novel lncRNAs in rBMSCs, the mapped reads (of each sample in rBMSCs) were assembled using the software Cufflinks version 2.2.1 and StringTie version 1.0.4 (in a reference-based approach) [74]. Cufflinks was also used for comparison of candidate sequences with the recognized lncRNAs [75]. The following procedure was used to select and identify putative novel lncRNAs: (1) transcripts length ≥ 200 bp were removed; (2) transcripts with multiple exons (transcript exon > 2/the number of exons > 1) and RPKM ≥ 2 were used; (3) transcripts overlap with known lncRNA on the opposite strand and the precursor transcript of mRNA were filted; (4) and transcripts predicted to be lncRNA were obtained by coding potential calculator (CPC) version v0.9-r2 [76], coding non coding index (CNCI) version 2.1 [77], and Pfamscan (Pfam) version 3.0 [78]. The obtained lncRNAs were classified according to their reference-based locations in the genome.

4.6. Differential Expression Genes Analysis of Transcripts

After mapping to the rat reference genome, the genes expression levels, related to the transcripts, were further quantified through the reads per kilo bases per million reads (RPKM) method, using HTSeq version 0.6.1 in Python [79]. Differentially expressed genes (DEG) of coding mRNAs and lncRNAs were detected through DEGseq2 version 1.4.5 [80]. Differentially expressed lncRNAs and mRNAs with statistical significance threshold of p-value < 0.05 and fold changes above 1.5 were assigned as being differentially expressed.

4.7. Bioinformatics Analysis

Pathway analysis for the differentially expressed mRNAs was conducted through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The Gene Ontology (GO) enrichment analysis of differentially expressed genes was performed using GOseq version 1.16.2 of R package (http://bioconductor.org/packages/release/bioc/html/goseq.html).

4.8. Target-Gene Prediction

Since lncRNA can cis- and trans-regulate target genes, protein-coding genes, found within 100 kb locations of chromosomes from the lncRNA, were screened out using R package and designated as lncRNA potential cis- regulated targets.
To investigate the trans- type interface, the Pearson’s correlations coefficients (r > 0.8 or r < −0.8) among lncRNA and protein-coding genes were examined. Cytoscape software (version 3.7.0; available online: www.cytoscape.org) was used to accomplish the co-expression-network analysis, and to determine the correlated expression of genes.

4.9. Quantitative Real-Time PCR Validation

Randomly chosen DEGs were used for the validation of RNA-seq results by qRT-PCR. Primer 6.0 software was used to design the gene-specific primers and synthesized by Sangon Biotech Company (Shanghai, China). The expression patterns of the chosen lncRNA and mRNAs were studied through qRT-PCR using RealmasterMix (SYBR Green, TIANGEN, China) following the manufacturer’s instructions. Gapdh mRNA was used as an internal control. The method 2−ΔΔCt method was used for the quantitative results to interpret the fold changes, followed by the statistical analysis. All the designed primer sequences are given in Table S1.

4.10. Statistical Analysis

All of our experiments were performed in three independent replicates (n = 3), and data are presented as mean ± SD. Unpaired students’ t-tests was performed to evaluate the differences between the CON group and LF group. Statistical significance was set at p < 0.05.

5. Conclusions

In conclusion, our study firstly investigated LF affected by the lncRNAs expression profiles during osteogenic differentiation of rBMSCs. These differentially expressed lncRNAs (60 up-regulated and 60 down-regulated) may contribute to the osteogenic differentiation of LF-treated rBMSCs via regulation of TGF-β and I-κappa B kinase/NF-κappa B signaling pathways. These results reveal LF-promoting osteogenic differentiation of rBMSCs was a complex process, not only by regulation of mRNAs, but also by regulation of lncRNAs expression. This study provides an experimental basis for further research regarding mechanisms that explain the effect of LF on osteogenic differentiation of MSCs.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/20/19/4834/s1.

Author Contributions

Y.X., H.-W.R., and N.L. conceived and designed the experiments, reviewed and editing the manuscript; Y.X., J.-J.A., D.T., Y.-D.X., and T.-Y.Z. contributed reagents, materials, analytical tools, and participated in the experiments; Y.X., D.T., and J.-J.A. analyzed the data; Y.X., H.-W.R., and N.L. wrote the manuscript. All authors approved the final version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ALPAlkaline phosphatase
BMSCsBone marrow mesenchymal stem cells
CNCICoding non coding index
COL ICollagen type I
CPCCoding potential Calculator
DEGDifferentially expressed gene
GOGene ontology
KEGGKyoto encyclopedia of genes and genomes.
LFLactoferrin
lncRNAsLong non-coding RNAs
MAPKMitogen-activated protein kinase
ncRNAsNon-coding RNAs
OCNOsteocalcin
PfamPfamscan
RNA-seqRNA Sequencing
RPKMReads per kilo bases per million reads

References

  1. Post, S.; Abdallah, B.M.; Bentzon, J.F.; Kassem, M. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone 2008, 43, 32–39. [Google Scholar] [CrossRef] [PubMed]
  2. Peng, X.B.; Zhang, Y.; Wang, Y.Q.; He, Q.; Yu, Q. IGF-1 and BMP-7 synergistically stimulate articular cartilage repairing in the rabbit knees by improving chondrogenic differentiation of bone-marrow mesenchymal stem cells. J. Cell. Biochem. 2019, 120, 5570–5582. [Google Scholar] [CrossRef] [PubMed]
  3. Chanda, D.; Kumar, S.; Ponnazhagan, S. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J. Cell. Biochem. 2010, 111, 249–257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Mao, L.; Wang, F.; Li, Y.Y.; Dai, Y.F.; Liu, Y.J.; Wang, J.F.; Xue, C.H. Oil from Antarctic krill (Euphausia superba) facilitates bone formation in dexamethasone-treated mice. Food Sci. Biotechnol. 2019, 28, 539–545. [Google Scholar] [CrossRef] [PubMed]
  5. Yamaguchi, M.; Weitzmann, M.N. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κappa B activation. Int. J. Mol. Med. 2012, 30, 708–712. [Google Scholar] [CrossRef]
  6. Li, M.; Zhang, C.; Li, X.H.; Lv, Z.H.; Chen, Y.; Zhao, J.Y. Isoquercitrin promotes the osteogenic differentiation of osteoblasts and BMSCs via the RUNX2 or BMP pathway. Connect. Tissue Res. 2019, 60, 189–199. [Google Scholar] [CrossRef] [PubMed]
  7. Chen, X.J.; Shen, Y.S.; He, M.G.; Yang, F.; Yang, P.; Pang, F.X.; He, W.; Cao, Y.M.; Wei, Q.S. Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/beta-catenin signaling pathway. Biomed. Pharmacother. 2019, 112, 108746. [Google Scholar] [CrossRef]
  8. Lootoing, L.; Davicco, M.J.; Lebecque, P.; Wittrant, Y.; Coxam, V. The flavonoid fisetin promotes osteoblasts differentiation through Runx2 transcriptional activity. Mol. Nutr. Food Res. 2014, 58, 1239–1248. [Google Scholar] [CrossRef]
  9. Fang, Y.Y.; Xue, Z.Y.; Zhao, L.G.; Yang, X.Y.; Yang, Y.F.; Zhou, X.L.; Feng, S.L.; Chen, K.M. Calycosin stimulates the osteogenic differentiation of rat calvarial osteoblasts by activating the IGF1R/PI3K/Akt signaling pathway. Cell Biol. Int. 2019, 43, 323–332. [Google Scholar] [CrossRef]
  10. Xu, Z.; Chen, H.; Wang, Z.Y.; Fan, F.J.; Shi, P.J.; Tu, M.L.; Du, M. Isolation and characterization of peptides from mytilus edulis with osteogenic activity in mouse MC3T3-E1 preosteoblast cells. J. Agric. Food Chem. 2019, 67, 1572–1584. [Google Scholar] [CrossRef]
  11. Ren, J.D.; Chakrabarti, S.; Wu, J.P. Phosvitin and its hydrolysate promote differentiation and inhibit TNF-alpha induced inflammation in MC3T3-E1 cells via ERK and AKT pathways. J. Funct. Foods 2019, 53, 259–265. [Google Scholar] [CrossRef]
  12. Gonzalez-Chavez, S.A.; Arevalo-Gallegos, S.; Rascon-Cruz, Q. Lactoferrin: Structure, function and applications. Int. J. Antimicrob. Agents 2009, 33, e1. [Google Scholar] [CrossRef] [PubMed]
  13. Gao, R.; Watson, M.; Callon, K.E.; Tuari, D.; Dray, M.; Naot, D.; Amirapu, S.; Munro, J.T.; Cornish, J.; Musson, D.S. Local application of lactoferrin promotes bone regeneration in a rat critical-sized calvarial defect model as demonstrated by micro-CT and histological analysis. J. Tissue Eng. Regen. Med. 2018, 12, E620–E626. [Google Scholar] [CrossRef] [PubMed]
  14. Li, W.Y.; Zhu, S.S.; Hu, J. Bone regeneration is promoted by orally administered bovine lactoferrin in a rabbit tibial distraction osteogenesis model. Clin. Orthop. Relat. Res. 2015, 473, 2383–2393. [Google Scholar] [CrossRef] [PubMed]
  15. Fan, F.J.; Shi, P.J.; Liu, M.; Chen, H.; Tu, M.L.; Lu, W.H.; Du, M. Lactoferrin preserves bone homeostasis by regulating the RANKL/RANK/OPG pathway of osteoimmunology. Food Funct. 2018, 9, 2653–2660. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, W.; Guo, H.Y.; Jing, H.; Li, Y.X.; Wang, X.Y.; Zhang, H.; Jiang, L.; Ren, F.Z. Lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of Lactoferrin’s receptor LRP1. J. Bone Miner. Res. 2014, 29, 1232–1243. [Google Scholar] [CrossRef]
  17. Ying, X.Z.; Cheng, S.W.; Wang, W.; Lin, Z.Q.; Chen, Q.Y.; Zhang, W.; Kou, D.Q.; Shen, Y.; Cheng, X.J.; Peng, L.; et al. Effect of lactoferrin on osteogenic differentiation of human adipose stem cells. Int. Orthop. 2012, 36, 647–653. [Google Scholar] [CrossRef]
  18. Li, Y.; Zhang, W.; Ren, F.; Guo, H. Activation of TGF-beta canonical and noncanonical signaling in bovine lactoferrin-induced osteogenic activity of C3H10T1/2 mesenchymal stem cells. Int. J. Mol. Sci. 2019, 20, 2880. [Google Scholar] [CrossRef]
  19. Grey, A.; Banovic, T.; Zhu, Q.; Watson, M.; Callon, K.; Palmano, K.; Ross, J.; Naot, D.; Reid, I.R.; Cornish, J. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 2004, 18, 2268–2278. [Google Scholar] [CrossRef]
  20. Liu, M.; Fan, F.J.; Shi, P.J.; Tu, M.L.; Yu, C.P.; Yu, C.X.; Du, M. Lactoferrin promotes MC3T3-E1 osteoblast cells proliferation via MAPK signaling pathways. Int. J. Biol. Macromol. 2018, 107, 137–143. [Google Scholar] [CrossRef]
  21. Li, Y.; Wang, J.; Ren, F.; Zhang, W.; Zhang, H.; Zhao, L.; Zhang, M.; Cui, W.; Wang, X.; Guo, H. Lactoferrin Promotes Osteogenesis through TGF-β Receptor II Binding in Osteoblasts and Activation of Canonical TGF-β Signaling in MC3T3-E1 Cells and C57BL/6J Mice. J. Nutr. 2018, 148, 1285–1292. [Google Scholar] [CrossRef] [PubMed]
  22. Peng, S.P.; Cao, L.H.; He, S.W.; Zhong, Y.C.; Ma, H.T.; Zhang, Y.R.; Shuai, C.J. An overview of long noncoding RNAs involved in bone regeneration from mesenchymal stem cells. Stem Cells Int. 2018, 2018, 11. [Google Scholar] [CrossRef] [PubMed]
  23. Huo, S.B.; Zhou, Y.C.; He, X.Y.; Wan, M.; Du, W.; Xu, X.; Ye, L.; Zhou, X.D.; Zheng, L.W. Insight into the role of long non-coding RNAs during osteogenesis in mesenchymal stem cells. Curr. Stem Cell Res. Ther. 2018, 13, 52–59. [Google Scholar] [CrossRef] [PubMed]
  24. Yang, Q.L.; Jia, L.F.; Li, X.B.; Guo, R.Z.; Huang, Y.P.; Zheng, Y.F.; Li, W.R. Long noncoding RNAs: New players in the osteogenic differentiation of bone marrow- and adipose-derived mesenchymal stem cells. Stem Cell Rev. Rep. 2018, 14, 297–308. [Google Scholar] [CrossRef]
  25. Lammens, T.; D’Hont, I.; D’Herde, K.; Benoit, Y.; Diez-Fraile, A. Long non-coding RNAs in pluripotent stem cell biology. Vet. Q. 2013, 33, 202–206. [Google Scholar] [CrossRef] [Green Version]
  26. Wei, B.F.; Wei, W.; Zhao, B.X.; Guo, X.X.; Liu, S. Long non-coding RNA HOTAIR inhibits miR-17-5p to regulate osteogenic differentiation and proliferation in nontraumatic osteonecrosis of femoral head. PLoS ONE 2017, 12, e0169097. [Google Scholar]
  27. Jin, C.Y.; Jia, L.F.; Huang, Y.P.; Zheng, Y.F.; Du, N.; Liu, Y.S.; Zhou, Y.S. Inhibition of lncRNA MIR31HG Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells. Stem Cells 2016, 34, 2707–2720. [Google Scholar] [CrossRef]
  28. Yoshioka, H.; Yoshiko, Y. The Roles of long non-protein-coding RNAs in osteo-adipogenic lineage commitment. Int. J. Mol. Sci. 2017, 18, 1239. [Google Scholar]
  29. Ju, C.; Liu, R.F.; Zhang, Y.W.; Zhang, Y.; Zhou, R.H.; Sun, J.; Lv, X.B.; Zhang, Z.P. Mesenchymal stem cell-associated lncRNA in osteogenic differentiation. Biomed. Pharmacother. 2019, 115, 108912. [Google Scholar] [CrossRef]
  30. Xie, Z.Y.; Wang, P.; Wu, Y.F.; Shen, H.Y. Long non-coding RNA: The functional regulator of mesenchymal stem cells. World J. Stem Cells 2019, 11, 167–179. [Google Scholar] [CrossRef]
  31. Zhuang, W.Z.; Ge, X.P.; Yang, S.J.; Huang, M.L.; Zhuang, W.Y.; Chen, P.; Zhang, X.H.; Fu, J.X.; Qu, J.; Li, B.Z. Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription. Stem Cells 2015, 33, 1985–1997. [Google Scholar] [CrossRef] [PubMed]
  32. Wang, C.G.; Liao, Z.; Xiao, H.; Liu, H.; Hu, Y.H.; Liao, Q.D.; Zhong, D. LncRNA KCNQ1OT1 promoted BMP2 expression to regulate osteogenic differentiation by sponging miRNA-214. Exp. Mol. Pathol. 2019, 107, 77–84. [Google Scholar] [CrossRef] [PubMed]
  33. Zhang, J.L.; Tao, Z.W.; Wang, Y.L. Long non-coding RNA DANCR regulates the proliferation and osteogenic differentiation of human bone-derived marrow mesenchymal stem cells via the p38 MAPK pathway. Int. J. Mol. Med. 2018, 41, 213–219. [Google Scholar] [CrossRef] [PubMed]
  34. Zhu, X.X.; Yu, J.J.; Du, J.; Zhong, G.S.; Qiao, L.; Lin, J.T. LncRNA HOXA-AS2 positively regulates osteogenesis of mesenchymal stem cells through inactivating NF-κappa B signalling. J. Cell. Mol. Med. 2019, 23, 1325–1332. [Google Scholar]
  35. Zheng, X.; Ning, C.; Zhao, P.; Feng, W.; Jin, Y.; Zhou, L.; Yu, Y.; Liu, J. Integrated analysis of long noncoding RNA and mRNA expression profiles reveals the potential role of long noncoding RNA in different bovine lactation stages. J. Dairy Sci. 2018, 101, 11061–11073. [Google Scholar] [CrossRef] [Green Version]
  36. Ruszkowska, M.; Nynca, A.; Paukszto, L.; Sadowska, A.; Swigonska, S.; Orlowska, K.; Molcan, T.; Jastrzebski, J.P.; Ciereszko, R.E. Identification and characterization of long non-coding RNAs in porcine granulosa cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Anim. Sci. Biotechnol. 2018, 9, 72. [Google Scholar] [CrossRef] [Green Version]
  37. Ma, Q.M.; Li, L.Y.; Tang, Y.; Fu, Q.; Liu, S.; Hu, S.W.; Qiao, J.; Chen, C.F.; Ni, W. Analyses of long non-coding RNAs and mRNA profiling through RNA sequencing of MDBK cells at different stages of bovine viral diarrhea virus infection. Res. Vet. Sci. 2017, 115, 508–516. [Google Scholar] [CrossRef]
  38. Billerey, C.; Boussaha, M.; Esquerre, D.; Rebours, E.; Djari, A.; Meersseman, C.; Klopp, C.; Gautheret, D.; Rocha, D. Identification of large intergenic non-coding RNAs in bovine muscle using next-generation transcriptomic sequencing. BMC Genom. 2014, 15, 499. [Google Scholar] [CrossRef]
  39. Włodarski, K. Lactoferrin a promising bone-growth promoting milk-derived glycoprotein. Chir. Narz. Ruchu. Ortop. Pol. 2009, 74, 257–259. [Google Scholar]
  40. Montesi, M.; Panseri, S.; Iafisco, M.; Adamiano, A.; Tampieri, A. Effect of hydroxyapatite nanocrystals functionalized with lactoferrin in osteogenic differentiation of mesenchymal stem cells. J. Biomed. Mater. Res. Part A 2015, 103, 224–234. [Google Scholar] [CrossRef]
  41. Park, S.Y.; Jeong, A.J.; Kim, G.Y.; Jo, A.; Lee, J.E.; Leem, S.H.; Yoon, J.H.; Ye, S.K.; Chung, J.W. Lactoferrin Protects Human Mesenchymal Stem Cells from Oxidative Stress-Induced Senescence and Apoptosis. J. Microbiol. Biotechnol. 2017, 27, 1877–1884. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Kim, S.E.; Yun, Y.P.; Shim, K.S.; Park, K.; Choi, S.W.; Suh, D.H. Effect of lactoferrin-impregnated porous poly(lactide-co-glycolide) (PLGA) microspheres on osteogenic differentiation of rabbit adipose-derived stem cells (rADSCs). Colloids Surf. B-Biointerfaces 2014, 122, 457–464. [Google Scholar] [CrossRef] [PubMed]
  43. An, J.; Xu, Y.; Kong, Z.; Xie, Y.; Tabys, D.; Ma, M.; Cao, X.; Ren, H.; Liu, N. Effect of lactoferrin and its digests on differentiation activities of bone mesenchymal stem cells. J. Funct. Foods 2019, 57, 202–210. [Google Scholar] [CrossRef]
  44. Zou, L.; Zou, X.; Chen, L.; Li, H.; Mygind, T.; Kassem, M.; Bunger, C. Multilineage differentiation of porcine bone marrow stromal cells associated with specific gene expression pattern. J. Orthop. Res. 2008, 26, 56–64. [Google Scholar] [CrossRef] [PubMed]
  45. Takayama, Y.; Mizumachi, K. Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells. J. Biosci. Bioeng. 2009, 107, 191–195. [Google Scholar] [CrossRef] [PubMed]
  46. Jiang, H.; Hong, T.; Wang, T.; Wang, X.; Cao, L.; Xu, X.; Zheng, M. Gene expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation. J. Cell. Physiol. 2019, 234, 7070–7077. [Google Scholar] [CrossRef]
  47. Wang, Z.; Jia, Y.; Du, F.; Chen, M.; Dong, X.; Chen, Y.; Huang, W. IL-17A Inhibits osteogenic Differentiation of bone mesenchymal stem cells via wnt signaling pathway. Med. Sci. Monit. 2017, 23, 4095. [Google Scholar] [CrossRef] [PubMed]
  48. Xie, Z.Y.; Tang, S.A.; Ye, G.W.; Wang, P.; Li, J.T.; Liu, W.J.; Li, M.; Wang, S.; Wu, X.H.; Cen, S.Z.; et al. Interleukin-6/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Stem Cell Res. Ther. 2018, 9, 13. [Google Scholar] [CrossRef]
  49. Li, G.; Liu, J.Y.; Zhao, M.Z.; Wang, Y.Y.; Yang, K.; Liu, C.; Xiao, Y.; Wen, X.J.; Liu, L.C. SOST, an LNGFR target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells. Cell Prolif. 2018, 51, e12412. [Google Scholar] [CrossRef]
  50. Kim, S.E.; Lee, D.W.; Yun, Y.P.; Shim, K.S.; Jeon, D.I.; Rhee, J.K.; Kim, H.J.; Park, K. Heparin-immobilized hydroxyapatite nanoparticles as a lactoferrin delivery system for improving osteogenic differentiation of adipose-derived stem cells. Biomed. Mater. 2016, 11, 025004. [Google Scholar] [CrossRef]
  51. Deng, L.D.; Hong, H.; Zhang, X.Q.; Chen, D.R.; Chen, Z.Y.; Ling, J.Q.; Wu, L.P. Down-regulated lncRNA MEG3 promotes osteogenic differentiation of human dental follicle stem cells by epigenetically regulating Wnt pathway. Biochem. Biophys. Res. Commun. 2018, 503, 2061–2067. [Google Scholar] [CrossRef] [PubMed]
  52. Lin, J.C.; Liu, Z.G.; Yu, B.; Zhang, X.R. MicroRNA-874 targeting SUFU involves in osteoblast proliferation and differentiation in osteoporosis rats through the hedgehog signaling pathway. Biochem. Biophys. Res. Commun. 2018, 506, 194–203. [Google Scholar] [CrossRef] [PubMed]
  53. Cui, J.; Zhang, W.W.; Huang, E.Y.; Wang, J.; Liao, J.Y.; Li, R.D.; Yu, X.Y.; Zhao, C.; Zeng, Z.Y.; Shu, Y.; et al. BMP9-induced osteoblastic differentiation requires functional Notch signaling in mesenchymal stem cells. Lab. Investig. 2019, 99, 58–71. [Google Scholar] [CrossRef] [PubMed]
  54. Feng, L.; Xue, D.T.; Chen, E.M.; Zhang, W.; Gao, X.; Yu, J.W.; Feng, Y.D.; Pan, Z.J. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Exp. Ther. Med. 2016, 12, 3941–3947. [Google Scholar] [CrossRef] [PubMed]
  55. Viti, F.; Landini, M.; Mezzelani, A.; Petecchia, L.; Milanesi, L.; Scaglione, S. Osteogenic differentiation of msc through calcium signaling activation: Transcriptomics and functional analysis. PLoS ONE 2016, 11, e0148173. [Google Scholar] [CrossRef] [PubMed]
  56. Zhang, W.; Wu, H.Y.; Li, Y.X.; Ren, F.Z.; Guo, H.Y. Lactoferrin-induced growth factors and cytokines expression profile in pre-osteoblast MC3T3-E1 cell and LRP1 stable knockdown MC3T3-E1 cell. J. Funct. Foods 2017, 37, 147–156. [Google Scholar] [CrossRef]
  57. Lu, Y.Z.; Zhao, Q.; Liu, Y.; Zhang, L.; Li, D.X.; Zhu, Z.L.; Gan, X.Q.; Yu, H.Y. Vibration loading promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells via p38 MAPK signaling pathway. J. Biomech. 2018, 71, 67–75. [Google Scholar] [CrossRef]
  58. He, Y.L.; de Castro, L.F.; Shin, M.H.; Dubois, W.; Yang, H.H.; Jiang, S.L.; Mishra, P.J.; Ren, L.; Gou, H.F.; Lal, A.; et al. p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells. Stem Cells 2015, 33, 1304–1319. [Google Scholar] [CrossRef]
  59. Artigas, N.; Gamez, B.; Cubillos-Rojas, M.; Sanchez-de Diego, C.; Valer, J.A.; Pons, G.; Rosa, J.L.; Ventura, F. p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation. Cell Death Differ. 2017, 24, 2022–2031. [Google Scholar] [CrossRef]
  60. Molchadsky, A.; Shats, I.; Goldfinger, N.; Pevsner-Fischer, M.; Olson, M.; Rinon, A.; Tzahor, E.; Lozano, G.; Zipori, D.; Sarig, R.; et al. p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner. PLoS ONE 2008, 3, e3707. [Google Scholar] [CrossRef]
  61. Kim, M.O.; Jung, H.; Kim, S.C.; Park, J.K.; Seo, Y.K. Electromagnetic fields and nanomagnetic particles increase the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Int. J. Mol. Med. 2015, 35, 153–160. [Google Scholar] [CrossRef] [PubMed]
  62. Xie, Z.Y.; Li, J.T.; Wang, P.; Li, Y.X.; Wu, X.H.; Wang, S.; Su, H.J.; Deng, W.; Liu, Z.H.; Cen, S.Z.; et al. Differential Expression Profiles of Long Noncoding RNA and mRNA of Osteogenically Differentiated Mesenchymal Stem Cells in Ankylosing Spondylitis. J. Rheumatol. 2016, 43, 1523–1531. [Google Scholar] [CrossRef] [PubMed]
  63. Cao, B.R.; Liu, N.; Wang, W.B. High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway. Biomed. Pharmacother. 2016, 84, 544–551. [Google Scholar] [CrossRef] [PubMed]
  64. Chen, S.; Jia, L.F.; Zhang, S.; Zheng, Y.F.; Zhou, Y.S. DEPTOR regulates osteogenic differentiation via inhibiting MEG3-mediated activation of BMP4 signaling and is involved in osteoporosis. Stem Cell Res. Ther. 2018, 9, 185. [Google Scholar] [CrossRef] [PubMed]
  65. Li, H.Q.; Zhang, Z.H.; Chen, Z.Q.; Zhang, D.D. Osteogenic growth peptide promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL13. Biochem. Biophys. Res. Commun. 2015, 466, 82–88. [Google Scholar] [CrossRef] [PubMed]
  66. Qiu, X.L.; Jia, B.; Sun, X.; Hu, W.T.; Chu, H.X.; Xu, S.M.; Zhao, J.J. The Critical Role of Long Noncoding RNA in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. Biomed. Res. Int. 2017, 2017, 11. [Google Scholar] [CrossRef]
  67. Nardocci, G.; Carrasco, M.E.; Acevedo, E.; Hodar, C.; Meneses, C.; Montecino, M. Identification of a novel long noncoding RNA that promotes osteoblast differentiation. J. Cell. Biochem. 2018, 119, 7657–7666. [Google Scholar] [CrossRef]
  68. Tye, C.E.; Gordon, J.A.R.; Martin-Buley, L.A.; Stein, J.L.; Lian, J.B.; Stein, G.S. Could lncRNAs be the Missing Links in Control of Mesenchymal Stem Cell Differentiation? J. Cell. Physiol. 2015, 230, 526–534. [Google Scholar] [CrossRef]
  69. Zhang, W.Y.; Dong, R.; Diao, S.; Du, J.; Fan, Z.P.; Wang, F. Differential long noncoding RNA/mRNA expression profiling and functional network analysis during osteogenic differentiation of human bone marrow mesenchymal stem cells. Stem Cell Res. Ther. 2017, 8, 30. [Google Scholar] [CrossRef]
  70. Li, H.L.; Fan, J.F.; Fan, L.Y.; Li, T.P.; Yang, Y.L.; Xu, H.Y.; Deng, L.C.; Li, J.; Li, T.; Weng, X.S.; et al. MiRNA-10b Reciprocally Stimulates Osteogenesis and Inhibits Adipogenesis Partly through the TGF-beta/SMAD2 Signaling Pathway. Aging Dis. 2018, 9, 1058–1073. [Google Scholar] [CrossRef]
  71. Kumar, A.; Kumar, V.; Rattan, V.; Jha, V.; Bhattacharyya, S. Secretome proteins regulate comparative osteogenic and adipogenic potential in bone marrow and dental stem cells. Biochimie 2018, 155, 129–139. [Google Scholar] [CrossRef] [PubMed]
  72. Wang, J.J.; Miao, J.; Meng, X.; Chen, N.; Wang, Y.L. Expression of long non-coding RNAs in human bone marrow mesenchymal stem cells co-cultured with human amnion-derived mesenchymal stem cells. Mol. Med. Rep. 2017, 16, 6683–6689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Kim, D.; Landmead, B.; Salzberg, S.L. HISAT: A fast spliced aligner with low memory requirements. Nat. Methods 2015, 12, 357. [Google Scholar] [CrossRef] [PubMed]
  74. Pertea, M.; Pertea, G.M.; Antonescu, C.M.; Chang, T.C.; Mendell, J.T.; Salzberg, S.L. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 2015, 33, 290. [Google Scholar] [CrossRef] [PubMed]
  75. Trapnell, C.; Roberts, A.; Goff, L.; Pertea, G.; Kim, D.; Kelley, D.R.; Pimentel, H.; Salzberg, S.L.; Rinn, J.L.; Pachter, L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7, 562–578. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Kong, L.; Zhang, Y.; Ye, Z.Q.; Liu, X.Q.; Zhao, S.Q.; Wei, L.; Gao, G. CPC: Assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 2007, 35, W345–W349. [Google Scholar] [CrossRef]
  77. Sun, L.; Luo, H.T.; Bu, D.C.; Zhao, G.G.; Yu, K.T.; Zhang, C.H.; Liu, Y.N.; Chen, R.S.; Zhao, Y. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res. 2013, 41, e166. [Google Scholar] [CrossRef] [PubMed]
  78. Mistry, J.; Bateman, A.; Finn, R.D. Predicting active site residue annotations in the Pfam database. BMC Bioinform. 2007, 8, 298. [Google Scholar] [CrossRef]
  79. Li, B.; Dewey, C.N. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011, 12, 323. [Google Scholar] [CrossRef]
  80. Love, M.I.; Huber, W.; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15, 550. [Google Scholar] [CrossRef] [Green Version]
Ijms 20 04834 g001 550
Figure 1. The osteogenic differentiation capacity of control rBMSCs (CON group) and Lactoferrin (LF)-treated rBMSCs (LF group). (A) Alkaline phosphatase (ALP) activity of rBMSCs on day 7, 14 and 21; (B) COLI expression of rBMSCs on day 7, 14 and 21; (C) Osteocalcin (OCN) expression of rBMSCs on day 7, 14 and 21; (D) Alizarin Red S staining, magnified images of rBMSCs of LF group and CON group (100×) on day 7, 14 and 21. Data are expressed as mean ± SD of three independent experiments (n = 3), the LF group was compared with CON group by unpaired student’s t-test (* p < 0.05, ** p < 0.01).
Figure 1. The osteogenic differentiation capacity of control rBMSCs (CON group) and Lactoferrin (LF)-treated rBMSCs (LF group). (A) Alkaline phosphatase (ALP) activity of rBMSCs on day 7, 14 and 21; (B) COLI expression of rBMSCs on day 7, 14 and 21; (C) Osteocalcin (OCN) expression of rBMSCs on day 7, 14 and 21; (D) Alizarin Red S staining, magnified images of rBMSCs of LF group and CON group (100×) on day 7, 14 and 21. Data are expressed as mean ± SD of three independent experiments (n = 3), the LF group was compared with CON group by unpaired student’s t-test (* p < 0.05, ** p < 0.01).
Ijms 20 04834 g001
Ijms 20 04834 g002 550
Figure 2. The lncRNAs identified during osteogenic differentiation of CON group and LF group. (A) Schematic diagram of the pipeline used for the identification of lncRNAs in rBMSCs. (B) The number of lncRNA identification was obtained of four steps. (C) Venn diagram showing lncRNAs identified by three types of software. (D) Classification of obtained novel lncRNAs according to their genomic positions, distribution of four types of lncRNAs among all 1301 lncRNAs.
Figure 2. The lncRNAs identified during osteogenic differentiation of CON group and LF group. (A) Schematic diagram of the pipeline used for the identification of lncRNAs in rBMSCs. (B) The number of lncRNA identification was obtained of four steps. (C) Venn diagram showing lncRNAs identified by three types of software. (D) Classification of obtained novel lncRNAs according to their genomic positions, distribution of four types of lncRNAs among all 1301 lncRNAs.
Ijms 20 04834 g002
Ijms 20 04834 g003 550
Figure 3. The comparison of features of lncRNAs and mRNAs. (A) Exon number. (B) ORF length. (C) Transcript count. (D) Transcript length. (E) Expression density distribution. Data are expressed by three independent experiments (n = 3).
Figure 3. The comparison of features of lncRNAs and mRNAs. (A) Exon number. (B) ORF length. (C) Transcript count. (D) Transcript length. (E) Expression density distribution. Data are expressed by three independent experiments (n = 3).
Ijms 20 04834 g003
Ijms 20 04834 g004 550
Figure 4. The effect of LF on expression profiles of differentially expressed lncRNAs and mRNAs of rBMSCs during osteogenic differentiation. (A,B) The unsupervised hierarchical clustering of heatmap show a distinguishable lncRNA or mRNA expression profile between the CON and LF groups. Each row represented one lncRNA or mRNA and each column represented a sample. Red color represented a high relative expression level; blue color represented a low relative expression level. (C,D) The volcano plot of lncRNA and mRNA expression in CON and LF groups. Each point represented one lncRNA or one mRNA. The red points (up-regulated) and green points (down-regulated) indicated a fold change (FC) in lncRNA or mRNA expression of more than 1.5-fold, and p value < 0.05. (E) The qRT-PCR results based on the analysis of the five differentially expressed lncRNAs in CON and LF groups. (F) The qRT-PCR results based on the analysis of the five differentially expressed mRNAs in CON and LF groups. Data describing the relative fold change are expressed as mean ± SD of three independent experiments (n = 3); ** p < 0.01.
Figure 4. The effect of LF on expression profiles of differentially expressed lncRNAs and mRNAs of rBMSCs during osteogenic differentiation. (A,B) The unsupervised hierarchical clustering of heatmap show a distinguishable lncRNA or mRNA expression profile between the CON and LF groups. Each row represented one lncRNA or mRNA and each column represented a sample. Red color represented a high relative expression level; blue color represented a low relative expression level. (C,D) The volcano plot of lncRNA and mRNA expression in CON and LF groups. Each point represented one lncRNA or one mRNA. The red points (up-regulated) and green points (down-regulated) indicated a fold change (FC) in lncRNA or mRNA expression of more than 1.5-fold, and p value < 0.05. (E) The qRT-PCR results based on the analysis of the five differentially expressed lncRNAs in CON and LF groups. (F) The qRT-PCR results based on the analysis of the five differentially expressed mRNAs in CON and LF groups. Data describing the relative fold change are expressed as mean ± SD of three independent experiments (n = 3); ** p < 0.01.
Ijms 20 04834 g004
Ijms 20 04834 g005 550
Figure 5. GO and pathway analysis of differentially expressed genes. (A) Enriched 30 GO analysis of DEGs. GO analysis covered the three domains biological process, cellular component and molecular function. (B) KEGG enrichment analysis of DEGs. The enrichment 30 pathways were shown.
Figure 5. GO and pathway analysis of differentially expressed genes. (A) Enriched 30 GO analysis of DEGs. GO analysis covered the three domains biological process, cellular component and molecular function. (B) KEGG enrichment analysis of DEGs. The enrichment 30 pathways were shown.
Ijms 20 04834 g005
Ijms 20 04834 g006 550
Figure 6. The co-expression network of LncRNA-target genes network. The co-expression network comprised 36 highly conserved lncRNAs and 146 mRNAs. The rectangles represent lncRNA, the circles represent target gene mRNAs. The red represents up regulated lncRNA, and blue represents down regulated lncRNA. The solid line represents cis-regulated targets, the marquee dash line represents trans-regulated targets. The delta target arrow shape represents positive correlation, the T target arrow shape represents negative correlation.
Figure 6. The co-expression network of LncRNA-target genes network. The co-expression network comprised 36 highly conserved lncRNAs and 146 mRNAs. The rectangles represent lncRNA, the circles represent target gene mRNAs. The red represents up regulated lncRNA, and blue represents down regulated lncRNA. The solid line represents cis-regulated targets, the marquee dash line represents trans-regulated targets. The delta target arrow shape represents positive correlation, the T target arrow shape represents negative correlation.
Ijms 20 04834 g006
Table
Table 1. RNA-Seq read mapping summary.
Table 1. RNA-Seq read mapping summary.
SampleTotal ReadsTotal Mapped ReadsUnique Mapped ReadsReads Mapped in PairedDetected Gene NumberDetected SNP NumberDetected InDel Number
CON 1152,017,08894.17%75.18%92.02%979350,6558142
CON 2151,919,04293.78%74.16%91.80%948546,5047442
CON 3152,842,64496.66%78.92%94.02%977750,1408047
LF 1151,975,65896.84%77.27%94.59%989051,3188190
LF 2152,415,43695.30%73.01%92.95%917143,6767003
LF 3151,898,67091.47%65.73%88.37%921942,5876739

Share and Cite

MDPI and ACS Style

Xu, Y.; An, J.-J.; Tabys, D.; Xie, Y.-D.; Zhao, T.-Y.; Ren, H.-W.; Liu, N. Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. Int. J. Mol. Sci. 2019, 20, 4834. https://doi.org/10.3390/ijms20194834

AMA Style

Xu Y, An J-J, Tabys D, Xie Y-D, Zhao T-Y, Ren H-W, Liu N. Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. International Journal of Molecular Sciences. 2019; 20(19):4834. https://doi.org/10.3390/ijms20194834

Chicago/Turabian Style

Xu, Yan, Jing-Jing An, Dina Tabys, Yin-Dan Xie, Tian-Yu Zhao, Hao-Wei Ren, and Ning Liu. 2019. "Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells" International Journal of Molecular Sciences 20, no. 19: 4834. https://doi.org/10.3390/ijms20194834

APA Style

Xu, Y., An, J.-J., Tabys, D., Xie, Y.-D., Zhao, T.-Y., Ren, H.-W., & Liu, N. (2019). Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. International Journal of Molecular Sciences, 20(19), 4834. https://doi.org/10.3390/ijms20194834

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop